Pharmx Technologies Ltd (PHX)

Sydney

Currency in AUD

0.070

+0.002(+0.00%)

Closed05/12

Fair Value

Day's Range

0.069

0.070

52 wk Range

0.012

0.080

PHX Income Statement

Featured here, the Income Statement (earnings report) for Pharmx Technologies Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

30/06

2016

30/06

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

Total Revenues

10.64

11.88

5.39

6.13

8.09

Total Revenues Growth

-5.23%

+11.58%

-54.65%

+13.78%

+32.1%

Cost Of Revenues

8.97

8.5

3.25

4.12

4.13

Gross Profit

1.67

3.38

2.14

2.01

3.96

Gross Profit Growth

-31.59%

+102.22%

-36.63%

-6.31%

+97.71%

Gross Profit Margin %

15.69%

28.44%

39.74%

32.72%

48.97%

Other Operating Expenses, Total

1.16

2.16

2.01

2.67

3.72

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-38.56%	+86.67%	-6.63%	+32.64%	+39.33%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.59	-0.62	-0.1	-0.09	-0.14
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.79	0.98	1.18	1.76	2.66
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.16	0.02	0.09	-	-

Operating Income

0.52

1.22

0.13

-0.67

0.24

Operating Income Growth

-8.2%

+137.09%

-89.6%

-623.62%

+136.69%

EBIT Margin %

4.84%

10.28%

2.36%

-10.85%

3.01%

Net Interest Expenses

-0.05

-0.13

-0.01

-0.05

-0.04

Net Interest Expenses Growth

-

-168%

+96.27%

-980%

+20.37%

Interest Expense, Total

-0.05

-0.13

-0.01

-0.05

-0.04

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

-

-

-

-

-

EBT, Excl. Unusual Items

0.47

1.09

0.12

-0.72

0.2

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-1.79

-1.47

-

-

-

EBT, Incl. Unusual Items

0.46

1.35

0.12

-0.72

0.2

EBT, Incl. Unusual Items Growth

+111.5%

+193.89%

-90.94%

-689.34%

+127.96%

EBT, Incl. Unusual Items Margin

4.3%

11.33%

2.27%

-11.73%

2.48%

Income Tax Expense

0.28

0.27

0.25

0.16

0.11

Net Income to Company

0.18

1.09

0.25

-1.05

-1.77

Minority Interest

-

-

-

-

-

Net Income

0.18

1.09

0.25

-1.05

-1.77

Net Income Growth

+104.19%

+519.89%

-76.9%

-517.06%

-68.32%

Net Income Margin %

1.65%

9.19%

4.68%

-17.15%

-21.86%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

0.18

1.08

-0.13

-0.88

0.1

Basic EPS - Continuing Operations

0

0

-0

-0

0

Basic EPS - Continuing Operations Growth

+103.1%

+290.18%

-111.03%

-574.89%

+110.69%

Diluted EPS - Continuing Operations

0

0

-0

-0

0

Diluted EPS - Continuing Operations Growth

+103.04%

+295.99%

-111.08%

-584.47%

+110.54%

Basic Weighted Average Shares Outstanding

345.38

542.63

596.76

597.17

598.18

Diluted Weighted Average Shares Outstanding

347.12

546.9

600.54

597.17

598.18

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

0.77

1.67

0.68

-0.22

0.53

EBITDA Growth

-10.4%

+117.34%

-59.27%

-132.25%

+342.01%

EBITDA Margin %

7.21%

14.04%

12.61%

-3.57%

6.55%

EBIT

0.52

1.22

0.13

-0.67

0.24